Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,584.79
(
-0.60%
)
US TECH 100
23,642.80
(
-0.64%
)
Dow Jones
45,881.21
(
-0.74%
)
Brent Oil
107.30
(
0.67%
)
Bitcoin
69,518.29
(
-2.42%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mouton29

Send PM Follow Ignore
Followers 24
Posts 2251
Boards Moderated 0
Alias Born 04/14/2007

mouton29

Member Level

Re: dewophile post# 85620

Saturday, 10/31/2009 12:52:47 PM

Saturday, October 31, 2009 12:52:47 PM

Post# of 257259
<<the HCV landscape now 3 years later has changed so much that it no longer makes much sense imo to bring 184, a more potent version of nm-283, forward>>

I'm not sure I followed your reasoning completely, it seems to me you were really saying, it no longer makes sense to bring 184 forward as a single agent , rather, it should be brought forward as part of a combination therapy, and NVS is not a suitable partner to do that.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now